STOCK TITAN

10x Genomics director proposes sale of 4,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

10x Genomics, Inc. director Sarah Amalia Polonius-Teichmann filed notice of a proposed sale of 4,000 common shares, with an approximate sale date of November 20, 2026. The notice lists an aggregate market value of $223,080 and identifies the shares as restricted stock acquired from the issuer on February 21, 2026. It also lists August 21, 2026, in the field for the plan-adoption or instruction date if relying on Rule 10b5-1.

Shares proposed for sale 4,000 shares Proposed sale by director Sarah Amalia Polonius-Teichmann
Aggregate market value $223,080 Shares proposed for sale
Approximate sale date November 20, 2026 Proposed sale
Shares outstanding 121,455,317 shares Issuer share count listed in the securities information
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Restricted Stock financial
"Nature of Acquisition Transaction: Restricted Stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many TXG shares does Sarah Amalia Polonius-Teichmann propose to sell?

The notice reports a proposed sale of 4,000 common shares, with an approximate sale date of November 20, 2026, and an aggregate market value of $223,080.

What date is listed for the TXG Rule 10b5-1 plan or instruction?

The notice lists August 21, 2026, in the field for the plan-adoption or instruction date if relying on Rule 10b5-1.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading